Effect of a Pediatric Prescription Medication Discharge Program on Reducing Hospital Readmission Rates

Insights

This study found that a pediatric prescription medication discharge program did not reduce hospital readmissions. The program

Area of Science:

  • Pediatric Healthcare
  • Hospital Readmission Research
  • Medication Management

Background:

  • Pediatric prescription medication discharge programs aim to improve patient outcomes.
  • Evaluating the effectiveness of such programs is crucial for optimizing healthcare delivery.
  • Hospital readmissions in pediatric populations represent a significant concern for healthcare systems.

Purpose of the Study:

  • To assess the impact of a pediatric prescription medication discharge delivery and counseling program.
  • To determine if the program effectively reduces 30-day hospital readmissions in pediatric patients.
  • To identify factors associated with readmission and program participation.

Main Methods:

  • Retrospective chart review of electronic medical records for patients under 21 years old.
  • Comparison of patients who participated in the discharge program versus non-participants.
  • Analysis of 30-day readmission rates, time to readmission, and diagnoses at discharge.

Main Results:

  • Out of 932 analyzed patients, 393 participated in the program.
  • The readmission rate was 13.2% for participants and 12.4% for non-participants (p = 0.717).
  • Diagnoses of malignancy and kidney injury were linked to higher readmission rates; heart defects and malignancy were linked to higher program participation.

Conclusions:

  • Participation in the pediatric discharge medication program did not significantly decrease 30-day hospital readmission rates.
  • The program's effectiveness in reducing readmissions requires further investigation.
  • Specific diagnoses may influence both readmission risk and program engagement.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
340
Discharge Summary Forms01:31

Discharge Summary Forms

The discharge summary is crucial as it enables a smooth transition from a healthcare facility to a patient's home or another care setting. This critical document facilitates seamless continuity of care, ensuring patients receive the necessary support and attention.
Here's a detailed look at the key components and guidelines for preparing a discharge summary:
1.3K
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
388
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
457
Pharmaceutical Poisoning: Potential Scenarios01:26

Pharmaceutical Poisoning: Potential Scenarios

Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
47
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
411